sinc
discoveri
tolllik
receptor
tlr
late
explos
research
describ
interact
hiv
innat
immun
system
emerg
literatur
work
fallen
two
broad
categori
elucid
cellular
machineri
signal
pathway
respons
recognit
hivderiv
pathogenassoci
molecular
pattern
pamp
examin
fate
innat
cell
contribut
control
viru
hivinfect
individu
recent
concept
emerg
unmitig
stimul
innat
immun
system
hiv
pamp
may
signific
contributor
system
immun
activ
associ
hiv
diseas
progress
final
number
studi
attempt
exploit
potenc
tlr
ligand
use
adjuv
enhanc
adapt
immun
number
preclin
vaccin
candid
potenti
microbicid
simian
immunodefici
viru
siv
macaqu
model
invalu
address
sever
question
primari
focu
chapter
summar
current
concept
interplay
innat
immun
hiv
infect
shape
work
done
sivmacaqu
model
chapter
divid
five
part
nonhuman
primat
nhp
model
siv
infect
innat
immun
sensor
hiv
siv
siv
infect
cellular
innat
immun
physic
mucos
immun
barrier
siv
infect
innat
immun
driver
immunopathogenesi
hivsiv
infect
vivo
administr
innat
ligand
nhp
sever
topic
peripher
innat
immun
cover
detail
within
chapter
beyond
scope
directli
address
adjoin
chapter
directli
describ
consider
research
adapt
immun
respons
siv
infect
major
histocompat
mhc
allel
associ
viral
control
discuss
detail
hivsiv
restrict
factor
experiment
inocul
asian
macaqu
speci
macaca
mulattarhesu
macaqu
rm
macaca
fasiculariscynomolgu
monkey
macaca
nemestrinapigtail
macaqu
sivmac
sivsmm
result
relev
nhp
model
vivo
infect
cours
diseas
progress
siv
infect
macaqu
proven
high
degre
variabl
depend
siv
isol
molecular
clone
diseas
sever
rang
low
none
case
clone
rapid
pronounc
observ
infect
caus
death
anim
month
postinfect
clinic
diseas
associ
sivmac
infect
asian
macaqu
strikingli
similar
observ
human
classifi
three
stage
acut
postacut
asymptomat
aid
acut
phase
occur
first
week
inocul
massiv
viremia
develop
accompani
larg
decreas
frequenc
absolut
number
lymphocyt
peripher
circul
gastrointestin
gi
tissu
clinic
sign
acut
phase
fever
lymphadenopathi
rash
malais
characterist
simian
aid
siv
infect
gener
enter
clinic
asymptomat
phase
viremia
control
maintain
stabl
set
point
lymphocyt
level
undergo
slow
continu
declin
later
aid
stage
sever
deplet
cell
concomit
occurr
opportunist
infect
protozo
infect
pneumocysti
jiroveci
usual
first
develop
howev
viral
typic
cytomegaloviru
adenoviru
simian
viru
bacteri
infect
mycobacterium
avium
also
preval
immunopatholog
includ
hyperplasia
within
lymphoid
follicl
earli
infect
switch
lymphoid
deplet
advanc
diseas
thymic
atrophi
inflamm
lung
also
common
pathogen
sivmac
virus
caus
death
aidslik
symptom
approxim
year
postinfect
similar
human
simian
aid
suggest
macaqu
model
highli
relev
high
effici
infect
challeng
also
make
use
model
vaccin
efficaci
studi
unlik
siv
infect
asian
macaqu
speci
infect
african
nhp
correspond
siv
induc
overtli
appreci
diseas
notabl
except
chimpanze
patholog
consist
aid
report
experiment
infect
sivcpz
infect
wild
best
character
natur
host
speci
sooti
mangabey
sm
african
green
monkey
agm
siv
infect
natur
host
share
phenotyp
similar
pathogen
infect
high
level
plasma
viremia
copiesml
tropism
cell
rapid
transient
deplet
mucos
cell
acut
infect
despit
similar
addit
remain
aidsfre
sm
agm
lack
mani
classic
clinic
featur
pathogen
hivsiv
maintain
stabl
number
peripher
blood
cell
display
bystand
lymphocyt
activ
mechan
sm
agm
remain
aidsfre
extens
studi
recent
year
sever
hypothes
emerg
review
ref
one
key
differ
appear
tropism
key
subset
cell
cell
sm
reduc
express
siv
coreceptor
central
memori
cell
tcm
tcm
cell
harbor
lower
level
siv
vivo
rel
effector
counterpart
tem
strong
invers
correl
diseas
progress
preserv
tcm
pool
demonstr
sivinfect
macaqu
abil
sm
shunt
bulk
siv
replic
away
subset
like
link
abil
maintain
stabl
bulk
tcell
number
precis
immunolog
mechan
natur
host
speci
remain
aidsfre
intens
investig
howev
remain
crucial
model
system
dissect
immunolog
aspect
siv
infect
differenti
aspect
normal
host
respons
viral
infect
dysregul
pathogen
immun
activ
driven
siv
discuss
detail
subsequ
recent
year
sever
studi
directli
compar
innat
immun
respons
siv
among
natur
pathogen
host
clear
pictur
differ
among
speci
begun
emerg
number
innat
receptor
demonstr
mediat
recognit
hiv
best
character
tlr
recogn
viralderiv
ssrna
viral
dna
current
knowledg
innat
recognit
come
vitro
studi
howev
exampl
studi
extend
primat
studi
typic
follow
aim
empir
test
innat
stimuli
adjuv
activ
candid
antihivsiv
vaccin
understand
contribut
innat
stimuli
pathogen
immun
activ
thorough
discuss
innat
immun
receptor
shown
recogn
hiv
found
iwasaki
toll
gene
correspond
protein
term
tlr
origin
describ
antifung
properti
drosophila
speci
eleven
mammalian
homolog
tlr
recogn
differ
compon
microb
call
pamp
identifi
date
differ
leukocyt
express
specif
profil
tlr
human
plasmacytoid
dendrit
cell
pdc
express
along
belong
tlr
subfamili
detect
pamp
intracellularli
tolllik
bind
singlestrand
viral
rna
wherea
bind
hypomethyl
cytosinephosphateguanin
cpg
dinucleotid
enrich
bacteri
dna
less
preval
eukaryot
dna
signal
occur
ligand
endocytos
transport
lysosom
compart
bind
cognat
receptor
ligandreceptor
complex
recruit
global
tlr
adaptor
molecul
initi
signal
cascad
transcript
factor
includ
nuclear
activ
cjun
ntermin
kinas
extracellular
signalregul
kinas
beststudi
tlr
recogn
hiv
siv
express
endosom
recogn
ssrna
express
high
level
pdc
signal
via
induc
high
express
interferonalpha
wherea
hiv
siv
induc
high
level
pdc
cell
product
infect
low
level
howev
nonproduct
intern
hiv
pdc
suffici
induc
secret
note
aldothiothreitolinactiv
siv
capabl
induc
high
level
induct
rm
sm
hivinfect
cell
potent
induc
ifn
product
pdc
purifi
virion
autophagi
requir
effici
ifn
product
suggest
infect
cell
rather
hiv
may
primari
stimuli
vivo
upon
stimul
interact
adaptor
molecul
activ
phosphoryl
transloc
nucleu
transactiv
type
ifn
transcript
viral
infect
associ
earli
endosom
initi
primarili
ifn
product
howev
feedback
mechan
induc
matur
endosom
consequ
ifn
produc
lead
upregul
surfac
costimulatori
molecul
contrast
virus
ligand
activ
hiv
caus
signal
complex
remain
sequest
earli
endosom
prolong
product
tolllik
receptor
recogn
hiv
express
within
endosom
requir
virion
fusion
deliveri
endosom
becom
activ
howev
recent
unclear
cytosol
recognit
hiv
occur
virion
harbor
two
positivesens
viral
rna
genom
rigi
famili
helicas
demonstr
recogn
viral
rna
cytoplasm
recent
report
hiv
genom
rna
activ
rigi
prototyp
member
famili
activ
rigi
viral
infect
cell
may
mask
hiv
abil
target
transcript
factor
degrad
suppress
ifnbeta
express
lattic
hiv
capsid
also
interact
restrict
factor
enhanc
innat
signal
final
endogen
receptor
hiv
dna
intermedi
aris
revers
transcript
hiv
genom
hypothes
activ
receptor
mask
cellular
express
host
exonucleas
digest
ssdna
prevent
hiv
dna
accumul
high
enough
level
stimul
asyet
undescrib
sensor
except
describ
subsequ
role
factor
infect
organ
level
either
human
nhp
yet
describ
restrict
factor
intracellular
protein
act
directli
block
viral
infect
intracellular
level
although
primarili
studi
activ
hiv
siv
vitro
recent
genet
data
demonstr
affect
viral
load
transmiss
siv
infect
wellstudi
restrict
factor
hiv
abl
demonstr
highli
effect
blockad
hiv
infect
vitro
restrict
factor
hypothes
import
safeguard
transmiss
lentivirus
speci
best
studi
lentivir
restrict
factor
human
low
activ
hiv
howev
rm
demonstr
much
higher
activ
vitro
siv
furthermor
macaqu
highli
polymorph
macaqu
inherit
restrict
allel
lower
viral
load
resist
lowdos
challeng
intrarect
penil
rout
importantli
studi
employ
sivsmm
strain
siv
group
shown
genotyp
effect
viral
replic
transmiss
sivmac
strain
owe
consider
influenc
viral
load
transmiss
preval
restrict
permiss
genotyp
import
consider
siv
vaccin
studi
primari
function
dendrit
cell
dc
act
potent
profession
antigenpres
cell
activ
adapt
immun
respons
resid
dc
site
infect
express
multitud
innat
pathogen
recognit
receptor
prr
describ
previous
plasma
membran
cytoplasm
endosom
recogn
pampcontain
structur
foreign
microorgan
virus
upon
recognit
dc
becom
activ
traffic
secondari
lymphoid
organ
present
foreign
antigen
via
mhc
class
ii
surfac
molecul
cell
manner
dc
repres
interfac
innat
adapt
immun
primari
import
modul
tcell
respons
modul
dc
respons
vaccin
adjuv
subject
interest
develop
hiv
vaccin
describ
methodolog
target
innat
machineri
subsequ
section
addit
past
decad
demonstr
hiv
siv
also
capabl
hijack
sentinel
dc
use
dissemin
primari
site
infect
secondari
lymphoid
organ
discuss
later
detail
unlik
lymphocyt
dc
classifi
cellsurfac
marker
anatom
locat
blood
beststudi
human
myeloid
dc
subset
typic
defin
lincel
sometim
refer
convent
classic
dc
cdc
phenotyp
cell
demonstr
similar
rm
sm
howev
rm
sever
lineag
marker
present
cdc
absent
human
counterpart
includ
recent
novel
blood
dc
subset
describ
human
dc
capabl
effici
crosspresent
repres
function
analog
mous
dc
howev
similar
subset
cell
report
yet
nhp
third
subset
nonmyeloid
blood
dc
pdc
discuss
subsequ
differ
significantli
myeloid
dc
primari
function
appear
secret
high
amount
rather
antigen
present
within
skin
mucosa
langerhan
cell
express
langerin
preval
epiderm
layer
two
dermal
dc
subset
recent
gutresid
dc
describ
rm
human
promot
toler
induct
tregulatori
cell
respons
maintain
homeostasi
gut
epitheli
barrier
describ
detail
later
interest
subset
also
notabl
deplet
mucosa
siv
infect
earli
studi
vagin
transmiss
model
siv
demonstr
siv
enter
mucosa
nonproduct
infect
resid
dc
lc
within
h
infect
howev
hivinfect
dc
detect
drain
ln
bind
ctype
lectin
receptor
dcsign
surfac
mucos
dc
potent
enhanc
transinfect
cell
similar
activ
demonstr
dcsign
dc
rm
chimpanze
agm
vitro
pdc
uniqu
subset
dc
present
low
frequenc
peripher
blood
unlik
dc
primari
function
pdc
seem
antigen
present
product
massiv
level
antivir
cytokin
pdc
express
high
level
interleukin
il
chain
well
although
function
still
defin
ident
neuron
receptor
axon
guidanc
factor
receptor
endotheli
tumor
cell
vascular
endotheli
growth
factor
vegfa
isol
pdc
characterist
smooth
round
cell
wherea
mdc
promin
dendrit
morpholog
differ
suggest
pdc
blood
gener
immatur
find
support
low
cell
surfac
express
tcell
co
timulatori
molecul
pdc
first
recogn
human
lymph
node
cell
plasma
cell
morpholog
devoid
b
cell
plasma
cell
marker
origin
refer
plasmacytoid
cell
close
associ
cell
lymph
node
nomenclatur
later
chang
plasmacytoid
monocyt
found
share
common
marker
myelomonocyt
cell
sever
research
group
recogn
concurr
stimul
peripher
blood
mononuclear
cell
pbmc
cultur
virus
virusinfect
cell
result
high
concentr
accumul
supernat
small
number
cell
appear
respons
bulk
product
cell
dub
natur
interferonproduc
cell
nipc
lack
b
nk
monocyt
marker
express
mhcii
molecul
clearli
distinct
classic
peripher
blood
dc
nearli
decad
independ
studi
siegal
et
al
cella
et
al
determin
plasmacytoid
monocyt
nipc
peripher
blood
secondari
lymphoid
tissu
cell
type
whereupon
design
pdc
adopt
respons
wide
rang
virus
bacteria
pdc
produc
pg
cell
greater
amount
produc
activ
monocyt
although
predomin
human
pdc
secret
subtyp
well
moder
level
interferon
regulatori
factor
irf
control
express
control
secret
respons
viru
infect
pdc
express
irf
gene
particular
constitut
express
high
level
detect
presenc
mrna
protein
level
high
level
constitut
express
pdc
thought
contribut
rapid
synthesi
respons
viru
infect
pdc
adept
recogn
becom
activ
respons
varieti
virus
includ
hepat
c
viru
hcv
human
tlymphotrop
viru
htlv
herp
simplex
viru
pdc
directli
link
resolut
diseas
respiratori
syncyti
viru
dengu
fever
viru
also
deplet
number
diseas
includ
htlv
hcv
sever
acut
respiratori
syndrom
sar
coronaviru
sarscov
hiv
pdc
well
studi
hiv
infect
human
pdc
stimul
vitro
infecti
inactiv
hiv
even
recombin
secret
upregul
compar
uninfect
control
circul
pdc
hivinfect
patient
express
higher
level
cell
surfac
although
mechan
hivmedi
pdc
activ
vitro
describ
activ
vivo
primarili
depend
pathway
contribut
overal
immun
activ
observ
advanc
hiv
diseas
howev
chronic
infect
hiv
patient
frequenc
absolut
number
circul
pdc
reduc
pdcdepend
product
ex
vivo
reduct
gener
correl
increas
viral
load
decreas
number
cell
downregul
express
pdc
hiv
patient
also
relat
viral
load
administr
highli
activ
antiretrovir
activ
circul
tcell
number
usual
increas
plasma
viremia
declin
howev
pdc
number
partial
restor
secret
remain
defect
furthermor
pdc
isol
hiv
patient
impair
abil
stimul
allogen
cell
harbor
provir
dna
also
transfer
viru
cell
cocultur
isol
use
infect
human
pdc
product
vitro
although
virus
tend
replic
effici
whole
pbmc
cultur
infect
strain
pdc
higher
provir
load
cell
suggest
pdc
preferenti
infect
similar
observ
hiv
pdc
deplet
demonstr
acut
chronic
siv
infect
rm
pigtail
cynomolgu
macaqu
nonpathogen
host
speci
siv
sm
agm
interestingli
studi
acut
pathogen
siv
infect
macaqu
demonstr
transient
increas
pdc
peripher
blood
rapid
egress
bone
marrow
follow
deplet
circul
pdc
accumul
apoptot
pdc
lymph
node
furthermor
recent
evid
multipl
laboratori
shown
pdc
necessarili
deplet
pathogen
siv
infect
rather
accumul
larg
number
gi
tract
note
phenomenon
appear
absent
nonpathogen
siv
infect
natur
killer
nk
cell
gener
thought
primari
effector
cell
innat
immun
system
although
nk
cell
prototyp
thought
cytotox
cell
among
first
cell
intersect
pathogen
elimin
neoplast
cell
also
recent
shown
signific
homeostat
regulatori
function
human
two
subset
nk
cell
predomin
domin
subset
peripher
blood
dim
primarili
mediat
cytotox
activ
secret
rel
littl
contrast
distinct
subset
hi
nk
cell
display
littl
cytotox
activ
secret
rel
larg
amount
hi
subset
also
express
domin
popul
found
lymph
node
tonsillar
tissu
mucos
nk
cell
also
identifi
throughout
digest
tract
labial
oropharyng
mucosa
larg
small
intestin
mucos
nk
cell
typic
found
within
lamina
propria
local
intraepitheli
tissu
multipl
mucos
nk
cell
subpopul
describ
human
macaqu
model
reveal
signific
divers
gener
express
low
level
cytotox
enzym
granzym
perforin
robust
secret
tumor
necrosi
nk
cell
also
found
throughout
femal
reproduct
tract
major
role
placent
implant
modul
pregnanc
signific
interest
nk
cell
biolog
context
tumor
biolog
infecti
diseas
includ
hivsiv
accur
definit
nk
cell
anim
model
includ
nhp
critic
import
recent
studi
accur
identifi
macaqu
nk
cell
peripher
blood
cell
divid
three
distinct
subpopul
major
nk
cell
popul
two
minor
popul
dim
hi
subsequ
public
anoth
group
valid
definit
macaqu
nk
cell
demonstr
appli
sm
function
profil
found
human
nk
cell
seem
analog
nhp
interestingli
wherea
nk
cell
predomin
peripher
blood
nk
cell
tissu
dn
nk
cell
long
shown
inhibit
hiv
replic
vitro
cultur
inhibit
ligandmedi
kill
domin
mechan
interestingli
acut
hiv
diseas
associ
expans
dim
nk
cell
subset
human
suggest
virusdriven
increas
cytolyt
activ
longterm
nonprogressor
increas
nk
cell
cytotox
compar
virem
individu
advent
precis
molecular
profil
recent
shown
put
ligand
hlab
also
associ
slower
diseas
progress
interact
two
molecul
lead
inhibit
replic
vitro
number
studi
suggest
nk
cell
help
mediat
control
siv
infect
nk
cell
shown
readili
lyse
sivinfect
cell
cell
puls
siv
acut
infect
induc
activ
macaqu
nk
cell
reflect
upregul
express
increas
lysi
suscept
cell
longitudin
studi
follow
siv
infect
demonstr
earli
nk
cell
respons
lead
longterm
viru
control
rm
well
natur
host
speci
sm
agm
mathemat
model
suggest
nk
cell
modul
siv
replic
diseas
outcom
sm
rm
siv
infect
nk
cell
mucosa
upregul
cytotox
function
overal
increas
mucos
home
nk
cell
evid
pigtail
macaqu
infect
siv
invers
associ
magnitud
nk
cell
respons
probabl
develop
neuroaid
observ
macaqu
studi
thu
far
yield
conflict
result
role
killer
cell
immunoglobulinlik
receptor
kir
control
siv
infect
studi
suggest
posit
control
presenc
cognat
ligand
other
suggest
kir
relat
loss
control
siv
replic
although
imperfect
macaqu
model
allow
partial
deplet
nk
cell
vivo
deplet
nk
cell
use
inhibitor
result
transient
increas
viral
load
suggest
may
role
nk
cell
regul
viral
control
howev
deplet
show
effect
earli
infect
studi
may
limit
inadequ
deplet
tissu
lack
effect
nk
cell
subpopul
although
nk
cell
gener
exert
function
either
cytolyt
regulatori
directli
target
cell
also
cooper
adapt
immun
system
antibodydepend
cellmedi
cytotox
adcc
respons
develop
within
first
week
postinfect
thought
typic
exert
nk
cell
also
involv
neutrophil
adcc
activ
associ
delay
progress
aid
sivinfect
macaqu
involv
efficaci
live
attenu
siv
vaccin
reduc
viral
load
variou
nonrepl
vaccin
modal
includ
hiv
vaccin
trial
antihiv
adcc
antibodi
also
observ
highli
expos
seroneg
individu
associ
control
viru
replic
hiv
elit
control
slow
progressor
anoth
promin
subset
mucosa
profoundli
affect
hiv
siv
infect
cell
subset
repres
independ
lineag
th
cell
popul
function
high
product
differenti
induc
transcript
factor
although
rare
peripheri
cell
highli
enrich
lamina
propria
lp
cell
function
coordin
innat
immun
bacteri
fungal
properti
regul
granulopoiesi
recruit
neutrophil
induct
antimicrobi
peptid
lymphocyt
also
integr
mainten
intact
epitheli
barrier
via
secret
act
epitheli
nonhematopoiet
cell
promot
differenti
prolifer
trigger
product
famili
protein
antimicrobi
compound
hiv
pathogen
siv
infect
deplet
mucosa
maintain
natur
host
sm
hivinfect
longterm
nonprogressor
also
maintain
higher
level
patient
progress
diseas
loss
cell
cell
type
innat
lymphoid
cell
ilc
cell
also
occur
pathogen
infect
semin
work
brenchley
douek
colleagu
show
pathogen
hiv
siv
infect
signific
amount
lp
microbi
byproduct
could
detect
plasma
process
term
microbi
transloc
mt
describ
greater
detail
subsequ
argu
natur
sequela
massiv
tcell
deplet
disrupt
lymphoid
architectur
observ
mucosa
could
signific
sourc
system
immun
activ
observ
hiv
siv
infect
later
raffatellu
et
al
demonstr
loss
cell
associ
transloc
salmonella
sivinfect
macaqu
provid
strong
evid
link
loss
breakdown
epitheli
barrier
role
seem
logic
consid
role
product
provid
anoth
link
loss
cell
siv
pathogenesi
demonstr
wherea
deplet
sivinfect
macaqu
maintain
infect
nonpathogen
speci
sm
mechan
cell
deplet
area
activ
investig
although
report
effici
infect
vitro
preferenti
infect
vivo
furthermor
cell
capabl
secret
bear
also
deplet
mucosa
siv
infect
suggest
mechan
independ
direct
infect
cell
one
like
mechan
may
loss
cell
deplet
cell
correl
loss
cell
exogen
given
attenu
loss
cell
siv
infect
altern
overlap
mechan
may
due
dysregul
metabol
activ
dc
apc
express
indoleamin
enzym
respons
catabol
tryptophan
activ
catabolit
invers
correl
level
hivinfect
individu
recent
subpopul
mucosaerestrict
cell
bear
featur
similar
nk
cell
cell
identifi
mice
human
rm
cell
term
ilc
partial
identifi
high
express
predomin
found
mucosaassoci
lymphoid
tissu
includ
compon
gi
tract
includ
gutdrain
lymph
node
tonsil
lung
ilc
express
high
level
cell
transcript
factor
share
phylogenet
lineag
lymphoid
tissueinduc
cell
lti
gener
noncytotox
secret
larg
quantiti
unfortun
due
limit
access
mucos
tissu
human
ilc
problemat
studi
function
nich
primat
unclear
caveat
partial
allevi
recent
descript
cell
type
nonhuman
primat
multipl
group
interestingli
siv
infect
ilc
massiv
deplet
number
significantli
alter
function
repertoir
furthermor
loss
ilc
neg
correl
breach
gut
epithelia
chronic
siv
infect
suggest
may
necessari
mainten
gut
homeostasi
link
like
function
relat
given
promin
role
play
regul
gut
integr
although
mechan
ilc
suppress
siv
infect
entir
clear
appear
partial
link
increas
solubl
inflammatori
mediat
gi
tract
accumul
indoleamin
catabolit
gener
rate
hivsiv
transmiss
absenc
vaccin
rel
low
partial
low
viru
infect
suffici
innat
immun
respons
howev
although
transmiss
event
occur
vagin
rectal
mucos
surfac
role
physic
barrier
tissu
block
transmiss
tradit
ignor
empir
evid
suggest
physic
barrier
may
limit
mani
transmiss
event
intraven
infect
barrier
obvious
absent
significantli
higher
rate
transmiss
compar
mucos
hiv
infect
furthermor
intraven
iv
infect
characterist
greater
number
viral
variant
mani
founder
virus
observ
sampl
intraven
drug
user
comparison
vagin
transmiss
typic
character
one
three
founder
popul
rectal
transmiss
experiment
cohort
men
sex
men
msm
greater
number
founder
viru
popul
vagin
transmiss
fewer
intraven
transmiss
final
although
founder
viru
popul
yet
enumer
case
oral
hiv
transmiss
rout
infect
gener
thought
ineffici
data
detail
rel
success
rate
viru
transmiss
variou
rout
offer
clue
substanti
role
physic
barrier
prevent
hiv
infect
viru
entri
breach
epitheli
layer
method
featur
role
mucos
epithelia
interestingli
hiv
evolv
disrupt
mucos
epithelia
even
absenc
infect
suggest
physic
barrier
put
select
pressur
viru
thu
ask
characterist
variou
epithelia
may
involv
delay
spread
viru
block
infect
entir
hiv
transmiss
occur
across
vagin
epithelia
transmiss
rate
higher
across
rectal
mucosa
mean
thick
human
epithelia
rectum
mm
compar
vagin
epithelia
mean
thick
mm
differ
rectal
mucosa
far
vulner
epitheli
breach
intercours
furthermor
vagin
epithelia
stratifi
squamou
arrang
layer
compar
singlelay
columnar
epithelium
rectal
mucosa
howev
thick
vagin
epitheli
layer
thin
luteal
phase
menstrual
cycl
result
increas
progesteron
level
elev
infect
rate
observ
period
fact
experiment
induc
thin
vagin
epithelia
macaqu
model
use
depoprovera
treatment
commonli
use
increas
infect
efficaci
intestin
epithelia
gener
thought
simpli
provid
physic
barrier
howev
activ
role
mucos
immun
product
broad
array
mucin
inflammatori
cytokin
chemokin
includ
capabl
block
hivsiv
infect
directli
increas
elast
vagin
mucu
low
ph
follicular
phase
also
thought
prevent
transmiss
luteal
phase
mucu
thin
increas
ph
correl
increas
transmiss
rate
cervicovagin
mucu
inhibit
hiv
diffus
penetr
provid
anoth
physic
barrier
infect
final
oral
hivsiv
infect
occur
low
rate
mothertochild
transmiss
debat
whether
sexual
oral
transmiss
occur
detect
frequenc
regardless
oral
transmiss
ineffici
compar
rout
transmiss
may
partli
particularli
strong
physic
barrier
oral
mucosa
includ
thickest
epitheli
layer
among
mucos
surfac
mean
thick
mm
oral
mucosa
also
bath
saliva
contain
multipl
salivari
proteas
amylas
known
inhibit
viru
infect
well
mucin
physic
trap
viru
particl
epitheli
line
includ
lumin
mucu
layer
provid
consider
physic
biochem
barrier
microb
chemic
barrier
includ
secretori
immunoglobulin
iga
defensin
regiii
protein
solubl
factor
underli
within
epitheli
line
complex
mucos
immun
system
compos
special
structur
divers
immunolog
subset
mucos
immun
system
face
uniqu
challeng
constant
barrag
foreign
antigen
repres
microbiota
present
intestin
lumen
mucos
compart
vibrantli
dynam
system
three
major
compon
epitheli
barrier
mucos
immun
structur
includ
cell
form
structur
commens
microbiota
activ
contribut
develop
homeostasi
system
whole
perturb
one
part
system
occur
hivsiv
infect
caus
signific
disrupt
other
structur
mucos
immun
system
sever
featur
analog
classic
immun
system
activ
adapt
respons
initi
induct
site
mesenter
ln
peyer
patch
pp
isol
lymphoid
follicl
ilf
cardin
featur
pp
ilf
distinguish
nonmucos
ln
encapsul
special
follicleassoci
epithelium
contain
pinocytot
cell
respons
sampl
antigen
content
intestin
lumen
present
b
cell
migrat
mucos
effector
site
lp
basal
layer
underli
gut
epithelium
within
intraepithelium
lymphocyt
compart
iel
mucos
immun
system
also
enrich
sever
uniqu
cellular
subset
found
minim
peripheri
immunoglobulin
aproduc
b
cell
plasma
cell
resid
lp
produc
polymer
iga
transport
intestin
lumen
contribut
solubl
immun
provid
extraepitheli
mucu
layer
within
iel
cell
either
heterodim
homodim
iel
compart
split
subset
resembl
convent
cell
enrich
cell
express
chain
frequenc
cell
tcell
popul
peripher
blood
compris
mucos
cell
gammadelta
cell
express
produc
chemokin
recruit
effector
cell
bacteri
infect
make
human
nhp
cell
express
tcr
popul
expand
abil
produc
impair
contrast
iel
cell
lamina
propria
express
lamina
propriaresid
cell
predominantli
activ
express
make
effici
target
hivsiv
infect
wherea
compart
heterogen
three
predomin
popul
treg
cell
fate
mucos
cell
hiv
siv
infect
well
studi
review
ref
undergo
rapid
massiv
deplet
larg
refractori
reconstitut
antiretrovir
art
administr
describ
earlier
diseas
progress
hiv
infect
demonstr
intim
link
persist
activ
immun
system
manifest
elev
rate
tcell
turnov
express
activ
marker
b
lymphocyt
elev
plasma
level
proinflammatori
cytokin
among
other
caus
immun
activ
like
multifactori
one
wide
accept
hypothes
persist
viru
provid
unab
stimuli
activ
innat
adapt
immun
system
howev
immun
activ
complet
erad
hivinfect
patient
effect
suppress
viru
institut
art
residu
immun
activ
virolog
respond
argu
result
low
level
viral
replic
could
also
caus
altern
mechan
immun
activ
independ
viral
replic
late
earli
sever
group
demonstr
hiv
siv
infect
caus
rapid
near
total
deplet
cell
gi
tract
find
led
brenchley
douek
propos
model
initi
insult
mucos
lymphocyt
compart
primari
infect
establish
perman
perturb
host
immun
system
shortli
thereaft
group
demonstr
elev
level
bacteri
structur
compon
lipopolysaccharid
lp
could
detect
plasma
hivinfect
patient
sivinfect
rm
absenc
overt
bacteremia
correl
lymphocyt
marker
immun
activ
find
provid
mechan
immunolog
damag
inflict
earli
infect
could
translat
chronic
immun
activ
view
led
coin
term
microbi
transloc
model
postul
deplet
gut
cell
result
disrupt
epitheli
barrier
structur
gi
tract
allow
penetr
microbi
byproduct
enter
system
circul
provid
continu
stimuli
innat
pattern
recognit
receptor
evid
elev
microbi
compon
plasma
hiv
infect
sinc
replic
sever
group
data
nhp
model
provid
direct
visual
lp
breach
mucos
barrier
sivinfect
rm
absenc
mt
natur
host
speci
help
link
mt
pathogenesi
studi
mt
hiv
infect
involv
detect
quantit
plasma
level
lp
use
appropri
assay
system
howev
model
demonstr
transloc
sever
microbi
byproduct
capabl
activ
multipl
prr
also
occur
includ
peptidoglycan
lipoteicho
acid
flagellin
cpg
motif
bacteri
dna
recent
expans
sever
viral
speci
demonstr
occur
mucosa
sivinfect
macaqu
yet
known
whether
virus
detect
system
transloc
product
correl
elev
level
proinflammatori
cytokin
moreov
express
coloc
bacteri
protein
gi
tract
sivinfect
rm
manner
microbi
transloc
may
altern
mechan
pathogen
stimul
viral
bacteri
innat
pathway
hiv
infect
chronic
viral
infect
effici
control
immun
system
remain
larg
latent
except
minor
burst
viral
replic
hiv
siv
differ
chronic
viral
infect
absenc
art
therapi
hiv
siv
replic
high
level
rna
copiesml
plasma
subject
life
persist
presenc
viral
particl
provid
perpetu
stimuli
innat
pattern
recognit
receptor
antigenspecif
cell
consid
one
primari
sourc
chronic
immun
activ
observ
pathogen
hivsiv
infect
unab
antigen
stimul
caus
immun
activ
tcell
deplet
extens
describ
recent
year
attent
direct
toward
effect
chronic
viru
replic
innat
system
particular
role
activ
pdc
subsequ
product
factor
drive
pathogenesi
garner
signific
interest
describ
earlier
exposur
hiv
particl
pdc
initi
high
level
inflammatori
cytokin
product
via
receptor
activ
transcript
factor
sever
line
vitro
evid
implic
pdc
andor
product
hiv
pathogenesi
pdc
activ
viral
particl
induc
apoptosi
tcell
upregul
tnfrelat
apoptosi
induc
ligand
hivderiv
rna
treatment
pdc
stimul
product
ido
skew
tcell
matur
toward
treg
develop
typic
suppress
antivir
immun
overview
model
contribut
pdc
chronic
immun
activ
summar
figur
pathogen
infect
rhesu
cynomolgu
pigtail
macaqu
siv
infect
initi
sustain
chronic
induct
interferonstimul
gene
isg
express
last
indefinit
similarli
persist
isg
express
detect
hivinfect
human
contrast
natur
host
siv
avoid
aid
sm
agm
demonstr
transient
isg
induct
disappear
chronic
infect
pdc
report
deplet
blood
sivinfect
rm
subsequ
studi
demonstr
reloc
mucosa
larg
number
rapidli
infect
coloc
strong
isg
express
plasmacytoid
dendrit
cell
accumul
gut
sivinfect
sm
absenc
longterm
isg
express
pdc
reloc
speci
resist
sivdiseas
suggest
aberr
activ
pdc
contribut
pathogenesi
hivsivinfect
human
macaqu
respect
molecular
mechan
underli
diverg
natur
host
pathogen
speci
current
unknown
previou
studi
report
product
sm
pdc
defect
speciesspecif
mutat
howev
observ
later
demonstr
larg
result
technic
error
sequenc
artifact
elucid
differ
innat
signal
pathway
pathogen
diseaseresist
model
speci
like
provid
valuabl
insight
molecular
basi
pathogenesi
recent
year
number
studi
attempt
manipul
innat
system
nhp
affect
siv
transmiss
rate
experiment
vaccin
studi
alter
diseas
progress
goal
studi
larg
fallen
two
categori
understand
role
innat
signal
caus
chronic
pathogen
immun
activ
siv
infect
test
efficaci
tlr
ligand
enhanc
protect
siv
challeng
consid
classic
studi
immun
activ
demonstr
stronger
predictor
mortal
diseas
progress
hiv
infect
count
andor
marker
complement
compar
studi
siv
infect
pathogen
nonpathogen
infect
rhesu
pigtail
macaqu
ultim
develop
diseas
siv
infect
show
widespread
innat
signal
interferon
respons
well
chronic
infect
contrast
nonpathogen
speci
agm
sm
rapidli
control
respons
preinfect
level
two
primari
pathway
implic
like
candid
pathogen
innat
signal
bacteri
ligand
associ
tlr
receptor
unab
stimul
innat
receptor
viral
pamp
provid
persist
replic
hivsiv
rational
bacteri
signal
stem
semin
studi
hivinfect
patient
sivinfect
macaqu
demonstr
elev
plasma
level
lp
owe
increas
infiltr
microparticl
gutresid
bacteria
phenomena
refer
microbi
transloc
thought
natur
sequela
massiv
deplet
mucos
cell
cell
mucos
dendrit
cell
subsequ
disrupt
mucos
structur
integr
logic
progress
microbi
transloc
model
two
studi
administ
lp
nonpathogen
siv
agm
determin
potenti
induc
immun
activ
manner
similar
seen
macaqu
singl
bolu
inject
lp
result
elev
activ
marker
cell
last
sever
day
followup
studi
use
multipl
dose
show
exogen
lp
could
also
induc
elev
level
coagul
marker
similar
observ
pathogen
siv
hiv
infect
facet
innat
system
consid
like
candid
drive
host
immun
activ
viral
prr
engag
persist
stimuli
provid
hivsiv
replic
persist
interferon
signal
observ
human
pathogen
host
nonpathogen
host
provid
rational
hypothesi
prolong
administr
viral
tlr
mice
result
lymphopenia
degrad
lymphoid
architectur
test
role
innat
signal
result
chronic
interferon
pathogenesi
vanderford
colleagu
administ
recombin
sivinfect
sm
otherwis
clinic
benign
although
elicit
transient
increas
activ
cell
activ
sustain
tcell
deplet
observ
blood
lymph
node
mucosa
recent
kader
colleagu
perform
reciproc
experi
attempt
block
signal
use
synthet
antagonist
sivinfect
rm
decreas
observ
tcell
activ
anim
receiv
blockad
compar
salin
control
howev
blockad
also
unabl
inhibit
express
interferonstimul
gene
vivo
made
difficult
interpret
link
isg
tcell
activ
yet
modul
innat
system
vivo
unabl
unequivoc
revers
sivrel
immun
activ
macaqu
attempt
break
nonpathogen
phenotyp
maintain
natur
host
use
vivo
manipul
innat
system
result
rel
modest
increas
activ
induc
widespread
dysregul
immun
system
observ
pathogen
host
like
reflect
consider
technic
difficulti
perform
vivo
intervent
nhp
mechan
immunopatholog
nonpathogenesi
multifactori
difficult
target
singl
modal
nevertheless
studi
provid
technic
framework
futur
studi
mani
effect
vaccin
live
attenu
strain
pathogen
date
live
attenu
siv
strain
demonstr
far
highest
efficaci
experiment
vaccin
siv
abil
protect
acquisit
challeng
studi
although
safeti
issu
preclud
use
live
attenu
hiv
human
vaccin
superior
protect
afford
whole
viru
fuel
inquiri
aim
defin
underli
immunolog
mechan
respons
contrast
subunit
vaccin
target
individu
viral
particl
combin
typic
much
poorer
immunogen
improv
vaccin
efficaci
shown
enhanc
use
adjuv
better
part
centuri
chiefli
accomplish
use
formul
aluminum
salt
oilwat
emuls
howev
past
decad
studi
vaccinolog
scienc
larg
shift
empir
scienc
reductionist
immunolog
continu
evolv
employ
highthroughput
omic
approach
wherea
concept
long
observ
nonself
signal
provid
live
attenu
organ
provid
robust
activ
signal
demonstr
individu
tlr
ligand
could
polar
tcell
respons
toward
activ
target
specif
dc
subtyp
suggest
manipul
innat
immun
system
could
result
finetun
vaccin
respons
sinc
earli
much
progress
made
understand
effect
adjuv
compos
bacteri
viral
tlr
ligand
affect
vaccin
respons
section
follow
review
data
deriv
tlr
adjuv
use
nhpsiv
vaccin
studi
rm
workhors
anim
model
test
evalu
candid
hiv
vaccin
primarili
owe
abil
infect
siv
experi
diseas
manner
highli
parallel
hiv
infect
human
howev
use
nhp
vaccin
preclin
develop
due
abil
infect
siv
adjuv
involv
stimul
tlr
prr
dc
yet
signific
differ
biolog
dc
popul
rodent
primat
well
cellular
distribut
tlr
compar
mice
nhp
share
much
higher
degre
similar
human
dc
popul
much
concord
cellular
express
prr
respons
ligand
addit
typic
administr
vaccin
mice
via
intraperiton
intraven
rout
rather
subcutan
intramuscular
rout
human
primat
lead
adjuvantsvaccin
present
differ
subset
dc
reason
adjuv
immunogen
data
deriv
rm
offer
direct
translat
human
studi
subsequ
increas
use
nhp
studi
nonsiv
vaccin
recent
year
earli
work
mice
demonstr
inject
either
agonist
ligand
cpg
oligodeoxynucleotid
capabl
elicit
high
level
cytokin
product
phenotyp
matur
convent
dc
poor
adjuv
rais
antigenspecif
tcell
activ
toward
hivgag
protein
howev
respons
could
improv
direct
conjug
gag
antigen
analogu
parallel
studi
perform
rm
demonstr
ligandgag
protein
conjug
significantli
enhanc
gagspecif
cell
cytokin
product
includ
enhanc
antibodi
avid
combin
ligandgag
conjug
addit
oilbas
adjuv
montanid
isa
also
led
enhanc
cytokin
releas
higher
degre
polyfunct
cytokin
respons
gagspecif
compar
gag
montanid
alon
enhanc
also
observ
boost
adenovir
vector
express
gag
direct
comparison
tlr
ligand
adjuv
use
gagprotein
primeadgag
boost
system
demonstr
gag
ligand
follow
gag
gag
ligand
effect
induc
gagspecif
cell
although
none
ligand
abl
augment
resist
siv
challeng
anim
receiv
tlr
adjuv
reduc
viremia
infect
kwissa
colleagu
observ
similar
effect
adjuv
improv
respons
vaccin
regimen
compos
dna
prime
modifi
vaccinia
viru
ankara
boost
abil
innat
adjuv
enhanc
immunogen
vaccin
becom
well
establish
howev
basic
experi
mice
demonstr
combin
tlr
ligand
togeth
singl
adjuv
formul
could
synergist
effect
improv
immunogen
even
principl
driven
home
dramat
studi
yellow
fever
vaccin
one
efficaci
vaccin
develop
demonstr
activ
follow
insight
kasturi
colleagu
develop
candid
composit
tlr
adjuv
nanoparticl
approxim
virus
term
size
carri
ligand
mpl
ligand
mice
monkey
enabl
longliv
antibodi
influenza
mice
rm
adjuv
regimen
current
preclin
studi
test
efficaci
siv
challeng
innat
immun
system
activ
ligand
demonstr
robust
abil
enhanc
immunogen
vaccin
applic
continu
intens
studi
howev
instanc
innat
stimuli
demonstr
detriment
host
immun
respons
siv
challeng
owe
abil
recruit
potenti
target
cell
site
infect
intravagin
applic
either
cpg
oligodeoxynucleotid
ligand
imiquimod
ligand
induc
proinflammatori
milieu
cellular
infiltr
cell
immun
cell
cervicovagin
mucosa
subsequ
highdos
challeng
siv
lead
protect
fact
anim
receiv
ligand
develop
higher
setpoint
viremia
compar
control
anim
convers
intravagin
treatment
monkey
glycerol
monolaur
antimicrobi
suppress
product
inflammatori
cytokin
chemokin
suppress
product
recruit
cell
remark
gml
treatment
led
protect
siv
transmiss
expos
intravagin
highdos
challeng
studi
demonstr
although
innat
immun
system
activ
ligand
robust
capac
enhanc
immunogen
immun
function
persist
respons
induc
vaccin
also
potenti
increas
target
cell
recruit
aid
infect
although
innat
immun
respons
induc
adjuv
expect
wane
shortli
vaccin
affect
target
cell
recruit
pauciti
data
longterm
effect
adjuv
earli
saw
explos
understand
innat
immun
system
cellular
molecular
level
descript
innat
system
provid
theoret
framework
understand
hiv
siv
caus
chronic
immun
activ
recent
year
sever
group
translat
murin
studi
use
innat
immun
system
activ
ligand
adjuv
empir
demonstr
modul
innat
immun
system
enhanc
vaccin
immunogen
primat
case
improv
protect
efficaci
siv
challeng
futur
research
effort
aim
optim
tlr
combin
defin
effect
target
cell
need
maxim
protect
potenti
vaccin
move
toward
clinic
trial
compar
studi
siv
infect
speci
develop
aid
natur
host
inform
highlight
differ
innat
immun
system
import
pathogenesi
final
hand
studi
begun
modul
innat
system
vivo
monkey
model
becom
increasingli
import
develop
therapeut
capabl
amelior
diseas
